A Randomised, Open-Label, Cross Over Group, Single-Centre Controlled Study To Evaluate The Clinical Performance Of Medium Cut-Off Membrane Dialyser Compared With High Flux Dialyser Among Patients With Chronic Haemodialysis
NACompletedINTERVENTIONAL
Enrollment
44
Participants
Timeline
Start Date
December 1, 2019
Primary Completion Date
June 1, 2020
Study Completion Date
December 31, 2021
Conditions
Hemodialysis-Associated AmyloidosisDialysis AmyloidosisQuality of Life
Interventions
DEVICE
Theranova 400
medium cut-off dialyser
DEVICE
Elisio-19H
high flux dialyser
Trial Locations (1)
68100
Selayang Hospital, Batu Caves
All Listed Sponsors
lead
Selayang Hospital
OTHER_GOV
NCT04160351 - A Randomised, Open-Label, Cross Over Group, Single-Centre Controlled Study To Evaluate The Clinical Performance Of Medium Cut-Off Membrane Dialyser Compared With High Flux Dialyser Among Patients With Chronic Haemodialysis | Biotech Hunter | Biotech Hunter